UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 5 Issue 12
December-2018
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR1812505


Registration ID:
193424

Page Number

29-35

Share This Article


Jetir RMS

Title

Pharmaceutical Patent Regime in India

Abstract

A new idea, expression, development or an innovative thought which comes out of human mind can be regarded as Intellectual property. Thus, Intellectual property rights (IPR) are those rights given to the creator that enables him to have exclusive use of his work, thereby, safeguarding his intellectual property. Copyrights, trademarks and patents are some of the various protections available for intellectual properties. Patent is an acknowledgment given to the creator for his work, which has originality and is non-conspicuousness. Various industries, like pharmaceuticals, are continuously working on new innovations and techniques for development. For better protection, identification, commercialization and insurance of such creativity and efforts, IPR becomes quite essential. A progressing IPR technique can be witnessed in the pharmaceutical industry these days which requires a better approach in the near future. This paper tends to provide a brief overview of advancement of patent law in India, specifically in the pharmaceutical industry, in consequence of TRIP agreement. The paper also delves to study and describe conditions of patentability and various kinds of patents granted in India to pharmaceutical industry aiming to provide basic concept of pharmaceutical patenting. Other significant laws in respect of pharmaceutical patenting, transfer and exchange of the rights so granted by the patents, mandatory licensing and likewise are discussed with appropriate cases

Key Words

IPR, Patents, Pharmaceutical products, TRIPS, Research & Development (R&D)

Cite This Article

"Pharmaceutical Patent Regime in India", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.5, Issue 12, page no.29-35, December-2018, Available :http://www.jetir.org/papers/JETIR1812505.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Pharmaceutical Patent Regime in India", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.5, Issue 12, page no. pp29-35, December-2018, Available at : http://www.jetir.org/papers/JETIR1812505.pdf

Publication Details

Published Paper ID: JETIR1812505
Registration ID: 193424
Published In: Volume 5 | Issue 12 | Year December-2018
DOI (Digital Object Identifier):
Page No: 29-35
Country: Ranchi, Jharkhand, India .
Area: Other
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0002834

Print This Page

Current Call For Paper

Jetir RMS